W. Taylor Kimberly
@wtkimberly
Physician-Scientist | Chief, Division of Neurocritical Care, @MGHNeuroICU, @MGHNeurology, @CGM_MGH, Massachusetts General Hospital | Harvard Medical School
ID: 1516691024
http://kimberlylab.massgeneral.org 14-06-2013 15:00:37
73 Tweet
544 Followers
145 Following
Now Online! 🗞️Analysis of #brain #edema in RHAPSODY journals.sagepub.com/doi/abs/10.117… Riana Schleicher W. Taylor Kimberly
Incredibly thankful to be awarded an @AHA Postdoc Fellowship at MGH Neurology @HarvardMed MGH Neurocritical Care to assess portable MRI Swoop® Portable MR Imaging® System–Hyperfine, Inc for hyperacute stoke detection using DWI-FLAIR mismatch. A huge thanks to @wtkkimberly @kevinsheth Matt Rosen plus every mentor who got me here!
#NMHpicks| 🔓🧠In a new Review in Nature Reviews Bioengineering, W. Taylor Kimberly et al. discuss the advantages of portable, low-field MRI that aims to democratize clinical brain #imaging. BISP MRI @ HKU The Center for Law, Brain, and Behavior go.nature.com/3NZy4u7
Our new study shows gut-related metabolites are associated with cerebral small vessel disease and stroke. This provides a link between diet, the gut microbiome, and markers of brain health. Naruchorn Kijpaisalratana MGH Neurology MGH Neurocritical Care MassGeneralNeuroscience jamanetwork.com/journals/jaman…
CHARM study shows no clear benefit of glibenclamide in large ischemic stroke. Results tended to be better with lesion volume of 120 ml or less. Future trial planned to analyze a revised patient population #ESOC2024 Kevin Sheth W. Taylor Kimberly
In a recent interview, W. Taylor Kimberly (MGH Neurology) comments on the results of the Phase III CHARM study, which randomized patients with large hemispheric infarction to IV glibenclamide or placebo: 👉 ow.ly/vxxF50ROHLB #Stroke #CTSM #TrialUpdate #NeuroTwitter #ESOC2024
A study co-authored by #MassGeneral physician W. Taylor Kimberly MD was covered by NeurologyLive®. The study found that that treatment with intravenous glibenclamide resulted in meaningful improvements in outcomes in patients with large hemispheric infarction. neurologylive.com/view/subgroup-…
A study co-authored by #MassGeneral physician W. Taylor Kimberly MD was covered by Safety+Health. The study found that reducing the amount of unprocessed food you eat can reduce your risk of a stroke or cognitive issues as you age. safetyandhealthmagazine.com/articles/25612…
In a study published in Neurology Journal, CGM at MGH investigator W. Taylor Kimberly & lab found associations between ultra-processed foods and risk of incident stroke and cognitive impairment in the REGARDS cohort. More info: bit.ly/454YfaT American Academy of Neurology MassGeneralNeuroscience @MGH_RI
#MassGeneral physician W. Taylor Kimberly MD was quoted in Las Vegas Review-Journal's article on the best and worst foods for brain health. reviewjournal.com/livewell/what-…
MGB #neurocritical care retreat brought together amazing clinicians from across MGH Neurocritical Care and Brigham and Women’s Neurocritical Care to talk about future growth, next directions and how to draw on all our strengths (and learn who’s the best at Cornhole Christopher Lancaste and Brian Edlow) #healthcare #neuro
@MGH_RI investigators integrate portable, low-field MRI with AI and show its potential to detect signs of Alzheimer's disease: nature.com/articles/s4146… W. Taylor Kimberly Juan Eugenio Iglesias Matt Rosen MGH Neurology MGH Martinos Center Mass General Imaging
Reimagining Alzheimer’s care with portable, low-field MRI! Excited to share our latest work in Nature Communications. Here, we show how low-field MRI paired with machine learning tools can detect patterns of brain atrophy in dementia patients—unlocking more accessible, scalable imaging.
Yes, scan do : MRI scanner + machine learning pipeline for portable #Alzheimers monitoring with no loss of resolution 📷: Dr Annabel Sorby-Adams et al W. Taylor Kimberly MassGeneralNeuroscience Harvard Medical School in Nature Communications ➡️: bpod.org.uk/archive/2024/1…
In a new Nature Communications study, researchers from the lab of W. Taylor Kimberly at MGH Neurocritical Care demonstrated that a portable MRI shows promise for expanding brain imaging for #Alzheimer's disease. Read more: massgeneralbrigham.org/en/about/newsr… doi.org/10.1038/s41467…